Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS scoreJoerg Hasford, Rüdiger Hehlmann, Michele Baccarani et al.|Blood|2011Cited by 497
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid LeukemiaClaude Preudhomme, François Guilhot, Christian Berthou et al.|New England Journal of Medicine|2010Cited by 385
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersFrancesca Bonifazi, Michele Baccarani, Antonio De Vivo et al.|Blood|2001Cited by 319
Risk factors analysis for pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumoniaF. Roblot, François Guilhot, Cendrine Godet et al.|Scandinavian Journal of Infectious Diseases|2004Cited by 40